Get 50% OFF This Monsoon!
Tejnaksh Healthcare
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Tejnaksh Healthcare Limited was incorporated in February 18, 2008. The Company is engaged in provision of hospital and healthcare and pharmacy services in Mumbai and other parts of Maharashtra. The Company has one subsidiary company, Tej Vedaant Healthcare Private Limited.
In innovations, the Company has more than 150 research papers, 23 innovations, 13 patents applied, multiple national and international awards and to top it off, have multiple records in the Guinness Book, Limca Book, Asia & Ripley's Book. Today, the Company takes pride in manufacturing and distribution of many patented products. Being one of the leading innovative healthcare providing brands in the country, the Company continues to fathom newer avenues, break through newer achievements and reach newer heights.
Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. The only healthcare IPO from the area and the speciality, the Company has been an ardent believer of high ethical and professional standards and focused on excellence in clinical services, diagnostic facilities and research. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company's achievements were the multiple records that motivates the customers to improve treatment for Urology.
The Company achieved the following milestones during the following years: In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , the Company established First Urology CME for the family physicians. In 2007, the Company set up 1st Laser Unit of North Maharashtra and 1st Flexible Ureteroscope of North Maharashtra. In 2008, the Company filed the 1st Innovation Patent. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination. In 2010, the Company was moved to the 1st Guinness World Record and established about 13 satellite centers. In 2011, the Company achieved the Records in Limca, Asia & Ripley's Book 2011 and Records in World Amazing Records, World Record Academy. In the same year, the company won the best research paper: Urological Society of India-WZ. In 2012, the Company won the S.S. Bapat prize for best innovation; it set up the First urology conference - Stonecon and hit the 2nd Guinness World Record. In 2013, the 5-PANG PCNL system became commercially available for the Company. The Company was won the S.S. Bapat Prize for Best Innovation during the year 2013. In 2014, the Company won the Second Guinness World Records. In the same year, the Company started first online opinion window for patients. In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic. It took the initiative to set up The International Health Tourism. In 2016, the Company set up the first indigenous PCNL simulation lab in the country. The PCNL simulators manufactured by Tejnaksh became commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center in Navi Mumbai during the year.
Tejnaksh Healthcare share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Tejnaksh Healthcare indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Tejnaksh Healthcare is valued compared to its competitors.
Tejnaksh Healthcare PE ratio helps investors understand what is the market value of each stock compared to Tejnaksh Healthcare 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Tejnaksh Healthcare evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Tejnaksh Healthcare generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Tejnaksh Healthcare in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Tejnaksh Healthcare shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Tejnaksh Healthcare compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Tejnaksh Healthcare over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Tejnaksh Healthcare helps investors get an insight into when they can enter or exit the stock. Key components of Tejnaksh Healthcare Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Tejnaksh Healthcare shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Tejnaksh Healthcare ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Tejnaksh Healthcare provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Tejnaksh Healthcare highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Tejnaksh Healthcare .
The balance sheet presents a snapshot of Tejnaksh Healthcare ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App